MBR None
MBR is a company founded in November 2006 that focuses on developing cancer immunotherapeutic agents for tuberculosis and nontuberculous mycobacterial infections.
MBR is a company founded in November 2006 that focuses on developing cancer immunotherapeutic agents for tuberculosis and nontuberculous mycobacterial infections.